These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 17644807

  • 21. Polymorphisms of estrogen receptor alpha gene in endometrial cancer.
    Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R.
    Biochem Biophys Res Commun; 2002 Sep 27; 297(3):558-64. PubMed ID: 12270131
    [Abstract] [Full Text] [Related]

  • 22. EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohort.
    Varella-Garcia M, Mitsudomi T, Yatabe Y, Kosaka T, Nakajima E, Xavier AC, Skokan M, Zeng C, Franklin WA, Bunn PA, Hirsch FR.
    J Thorac Oncol; 2009 Mar 27; 4(3):318-25. PubMed ID: 19247083
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC, Schafer JM, Pearce ST, Osipo C, Chen B, Jordan VC.
    Gynecol Oncol; 2002 Jun 27; 85(3):498-506. PubMed ID: 12051881
    [Abstract] [Full Text] [Related]

  • 25. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
    Konac E, Onen HI, Metindir J, Alp E, Biri AA, Ekmekci A.
    Cancer Detect Prev; 2007 Jun 27; 31(2):102-9. PubMed ID: 17418979
    [Abstract] [Full Text] [Related]

  • 26. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N, Oshita T, Fujii T, Kioka H, Katsube Y, Ohama K.
    Oncol Rep; 2000 Jun 27; 7(3):551-9. PubMed ID: 10767367
    [Abstract] [Full Text] [Related]

  • 27. Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma.
    Jiang XF, Tang QL, Shen XM, Li HG, Chen LH, Wang XY, Luo X, Lin ZQ, Jiang GY.
    Pathol Res Pract; 2012 Dec 15; 208(12):730-5. PubMed ID: 23122929
    [Abstract] [Full Text] [Related]

  • 28. Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.
    Han X, Diao L, Xu Y, Xue W, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y.
    Ann Oncol; 2014 Jun 15; 25(6):1158-64. PubMed ID: 24608202
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
    Zhang W, Gordon M, Press OA, Rhodes K, Vallböhmer D, Yang DY, Park D, Fazzone W, Schultheis A, Sherrod AE, Iqbal S, Groshen S, Lenz HJ.
    Pharmacogenet Genomics; 2006 Jul 15; 16(7):475-83. PubMed ID: 16788380
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas.
    Gow CH, Chang HT, Lim CK, Liu CY, Chen JS, Shih JY.
    Genes Chromosomes Cancer; 2017 May 15; 56(5):373-381. PubMed ID: 28063177
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Single nucleotide polymorphism in DNA base excision repair genes XRCC1 and hOGG1 and the risk of endometrial carcinoma in the Polish population.
    Romanowicz-Makowska H, Smolarz B, Houli A, Szyłło K.
    Pol J Pathol; 2011 May 15; 62(2):89-94. PubMed ID: 21866464
    [Abstract] [Full Text] [Related]

  • 36. GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients.
    Sasaki M, Karube A, Karube Y, Watari M, Sakuragi N, Fujimoto S, Dahiya R.
    Biochem Biophys Res Commun; 2005 Apr 01; 329(1):100-4. PubMed ID: 15721279
    [Abstract] [Full Text] [Related]

  • 37. Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
    Yue L, Wentao L, Xin Z, Jingjing H, Xiaoyan Z, Na F, Tonghui M, Dalin L.
    Medicine (Baltimore); 2020 Dec 18; 99(51):e23406. PubMed ID: 33371069
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Polymorphisms of glutathione-s-transferase M1, T1, and P1 genes in endometrial carcinoma.
    Ozerkan K, Atalay MA, Yakut T, Doster Y, Yilmaz E, Karkucak M.
    Eur J Gynaecol Oncol; 2013 Dec 18; 34(1):42-7. PubMed ID: 23589999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.